JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.9% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
OrthoPediatrics
KIDS
$653M
| $1.5M | ﹤0.01% |
33,953
+9,164
| +37% | +$349K |
|
3377
Neuronetics
STIM
$211M
| $1.5M | ﹤0.01% |
98,471
+51,143
| +108% | +$846K |
|
3378
Markel Group
MKL
$22.8B
| $1.5M | ﹤0.01% |
1,501
-4,772
| -76% | -$4.85M |
|
3379
PUT
TG Therapeutics
TGTX
$7.34B
| $1.49M | ﹤0.01% |
+185,700
| New | +$1M |
|
3380
CapForce IBD 50 ETF
FFTY
$80.5M
| $1.49M | ﹤0.01% |
44,505
+44,170
| +13,185% | +$1.39M |
|
3381
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
| $1.49M | ﹤0.01% |
21,958
+3,000
| +16% | +$195K |
|
|
AQUA
3382
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.49M | ﹤0.01% |
118,150
-49,841
| -30% | -$593K |
|
3383
Sierra Bancorp
BSRR
$532M
| $1.49M | ﹤0.01% |
61,087
+2,991
| +5% | +$77.6K |
|
3384
Frontdoor
FTDR
$5.83B
| $1.49M | ﹤0.01% |
43,142
-4,854
| -10% | -$148K |
|
|
AVDR
3385
DELISTED
Avedro, Inc Common Stock
AVDR
| $1.49M | ﹤0.01% |
+121,014
| New | +$1.51M |
|
|
PENG
3386
Penguin Solutions Inc
PENG
$3.12B
| $1.48M | ﹤0.01% |
154,614
+145,004
| +1,509% | +$1.88M |
|
|
BNY
3387
PUT
Bank of New York Mellon
BNY
$110B
| $1.48M | ﹤0.01% |
29,300
-93,100
| -76% | -$4.8M |
|
3388
Genco Shipping & Trading
GNK
$1.13B
| $1.48M | ﹤0.01% |
197,973
+127,550
| +181% | +$1.04M |
|
3389
FerroAtlántica
GSM
$818M
| $1.47M | ﹤0.01% |
718,617
+365,159
| +103% | +$831K |
|
3390
Aclaris Therapeutics
ACRS
$863M
| $1.47M | ﹤0.01% |
245,804
+51,660
| +27% | +$342K |
|
3391
NIO
NIO
$11.3B
| $1.47M | ﹤0.01% |
+288,448
| New | +$2.04M |
|
|
WTRE
3392
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1.47M | ﹤0.01% |
+55,000
| New | +$1.48M |
|
|
USX
3393
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.47M | ﹤0.01% |
222,477
+63,338
| +40% | +$492K |
|
3394
Franklin Electric
FELE
$4.75B
| $1.47M | ﹤0.01% |
28,764
-33,527
| -54% | -$1.65M |
|
3395
Onto Innovation
ONTO
$20.6B
| $1.47M | ﹤0.01% |
47,511
-7,773
| -14% | -$229K |
|
3396
Tenable Holdings
TENB
$4.41B
| $1.46M | ﹤0.01% |
46,264
+43,047
| +1,338% | +$1.22M |
|
|
UHT
3397
Universal Health Realty Income Trust
UHT
$573M
| $1.46M | ﹤0.01% |
19,343
-9,376
| -33% | -$668K |
|
3398
CALL
Karyopharm Therapeutics
KPTI
$45.1M
| $1.46M | ﹤0.01% |
+16,667
| New | +$1.85M |
|
3399
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.16B
| $1.46M | ﹤0.01% |
14,752
+6,423
| +77% | +$620K |
|
3400
CALL
PagSeguro Digital
PAGS
$2.43B
| $1.46M | ﹤0.01% |
+48,800
| New | +$1.22M |
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,671 reduced and 538 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 538 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.